Skip to main content
Top
Published in: Pediatric Nephrology 12/2017

01-12-2017 | Educational Review

Enhancing dialyser clearance—from target to development

Authors: Kamonwan Tangvoraphonkchai, Andrew Davenport

Published in: Pediatric Nephrology | Issue 12/2017

Login to get access

Abstract

Products of metabolism accumulate in kidney failure and potentially have toxic effects. Traditionally these uraemic toxins are classified as small, middle-sized and protein-bound toxins, and clearance during dialysis is affected by diffusion, convection and adsorption. As current dialysis practice effectively clears small solutes, increasing evidence supports a toxic effect for middle-sized and protein-bound toxins. Therefore, newer approaches to standard dialysis practice are required to look beyond urea clearance. Current dialysers have been developed to effectively clear small solutes and secondly to increase middle-sized toxin clearances. However, there is no ideal dialyser which can effectively clear all uraemic toxins. Advances in nanotechnology have led to improvements in manufacturing, with the production of smoother membrane surfaces and uniformity of pore size. The introduction of haemodiafiltration has led to changes in dialyser design to improve convective clearances. Both diffusional and convectional clearances can be increased by changing dialyser designs to alter blood and dialysate flows, and novel dialyser designs using microfluidics offer more efficient solute clearances. Adjusting surface hydrophilicity and charge alter adsorptive properties, and greater clearance of protein-bound toxins can be achieved by adding carbon or other absorptive monoliths into the circuit or by developing composite dialyser membranes. Other strategies to increase protein-bound toxins clearances have centred on disrupting binding and so displacing toxins from proteins. Just as the hollow fibre design replaced the flat plate dialyser, we are now entering a new era of dialyser designs aimed to increase the spectrum of uraemic toxins which can be cleared by dialysis.
Literature
2.
go back to reference Ronco C, Brendolan A, Everard P, Irone M, Ballestri M, Cappelli G, Inguaggiato P, Bellomo R (1999) Cellulose triacetate: another membrane for continuous renal replacement therapy. J Nephrol 12:241–247PubMed Ronco C, Brendolan A, Everard P, Irone M, Ballestri M, Cappelli G, Inguaggiato P, Bellomo R (1999) Cellulose triacetate: another membrane for continuous renal replacement therapy. J Nephrol 12:241–247PubMed
3.
go back to reference Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M (2002) Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol 13[Suppl 1]:S53–S61PubMed Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M (2002) Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique. J Am Soc Nephrol 13[Suppl 1]:S53–S61PubMed
4.
go back to reference Shibata E, Nagai K, Takeuchi R, Noda Y, Makino T, Chikata Y, Hann M, Yoshimoto S, Ono H, Ueda S, Tamaki M, Murakami T, Matsuura M, Abe H, Doi T (2015) Re-evaluation of pre-pump arterial pressure to avoid inadequate dialysis and hemolysis: importance of prepump arterial pressure monitoring in hemodialysis patients. Artif Organs 39:627–634CrossRefPubMed Shibata E, Nagai K, Takeuchi R, Noda Y, Makino T, Chikata Y, Hann M, Yoshimoto S, Ono H, Ueda S, Tamaki M, Murakami T, Matsuura M, Abe H, Doi T (2015) Re-evaluation of pre-pump arterial pressure to avoid inadequate dialysis and hemolysis: importance of prepump arterial pressure monitoring in hemodialysis patients. Artif Organs 39:627–634CrossRefPubMed
5.
go back to reference Asano M, Thumma J, Oguchi K, Pisoni RL, Akizawa T, Akiba T, Fukuhara S, Kurokawa K, Ethier J, Saran R, Saito A, Group JDR (2013) Vascular access care and treatment practices associated with outcomes of arteriovenous fistula: international comparisons from the Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract 124:23–30CrossRefPubMed Asano M, Thumma J, Oguchi K, Pisoni RL, Akizawa T, Akiba T, Fukuhara S, Kurokawa K, Ethier J, Saran R, Saito A, Group JDR (2013) Vascular access care and treatment practices associated with outcomes of arteriovenous fistula: international comparisons from the Dialysis Outcomes and Practice Patterns Study. Nephron Clin Pract 124:23–30CrossRefPubMed
6.
go back to reference Ferraro B, Galli F, Frei B, Kingdon E, Canestrari F, Rice-Evans C, Buoncristiani U, Davenport A, Moore KP (2003) Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. Kidney Int 63:2207–2213CrossRefPubMed Ferraro B, Galli F, Frei B, Kingdon E, Canestrari F, Rice-Evans C, Buoncristiani U, Davenport A, Moore KP (2003) Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients. Kidney Int 63:2207–2213CrossRefPubMed
7.
go back to reference Davenport A (2014) How can dialyzer designs improve solute clearances for hemodialysis patients? Hemodial Int Suppl 1:S43–S47CrossRef Davenport A (2014) How can dialyzer designs improve solute clearances for hemodialysis patients? Hemodial Int Suppl 1:S43–S47CrossRef
8.
go back to reference Lim H-C, Lee S-J (2004) Flow control of a circular cylinder with O-rings. Fluid Dyn Res 35:107–122CrossRef Lim H-C, Lee S-J (2004) Flow control of a circular cylinder with O-rings. Fluid Dyn Res 35:107–122CrossRef
9.
go back to reference Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G (2002) Hemodialyzer: from macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. Kidney Int Suppl 80:126–142CrossRef Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G (2002) Hemodialyzer: from macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers. Kidney Int Suppl 80:126–142CrossRef
10.
go back to reference Hirano A, Yamamoto K, Matsuda M, Ogawa T, Yakushiji T, Miyasaka T, Sakai K (2011) Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance. Ther Apher Dial 15:66–74CrossRefPubMed Hirano A, Yamamoto K, Matsuda M, Ogawa T, Yakushiji T, Miyasaka T, Sakai K (2011) Evaluation of dialyzer jacket structure and hollow-fiber dialysis membranes to achieve high dialysis performance. Ther Apher Dial 15:66–74CrossRefPubMed
11.
go back to reference Yamamoto K, Matsuda M, Hirano A, Takizawa N, Iwashima S, Yakushiji T, Fukuda M, Miyasaka T, Sakai K (2009) Computational evaluation of dialysis fluid flow in dialyzers with variously designed jackets. Artif Organs 33:481–486CrossRefPubMed Yamamoto K, Matsuda M, Hirano A, Takizawa N, Iwashima S, Yakushiji T, Fukuda M, Miyasaka T, Sakai K (2009) Computational evaluation of dialysis fluid flow in dialyzers with variously designed jackets. Artif Organs 33:481–486CrossRefPubMed
12.
go back to reference Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17:546–555CrossRefPubMed Cheung AK, Rocco MV, Yan G, Leypoldt JK, Levin NW, Greene T, Agodoa L, Bailey J, Beck GJ, Clark W, Levey AS, Ornt DB, Schulman G, Schwab S, Teehan B, Eknoyan G (2006) Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. J Am Soc Nephrol 17:546–555CrossRefPubMed
13.
go back to reference Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis Study G (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med 347:2010–2019CrossRefPubMed Eknoyan G, Beck GJ, Cheung AK, Daugirdas JT, Greene T, Kusek JW, Allon M, Bailey J, Delmez JA, Depner TA, Dwyer JT, Levey AS, Levin NW, Milford E, Ornt DB, Rocco MV, Schulman G, Schwab SJ, Teehan BP, Toto R, Hemodialysis Study G (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. New Engl J Med 347:2010–2019CrossRefPubMed
14.
go back to reference Sakai K, Matsuda M (2011) Solute removal efficiency and biocompatibility of the high-performance membrane - from engineering points of view. Contrib Nephrol 173:11–22CrossRefPubMed Sakai K, Matsuda M (2011) Solute removal efficiency and biocompatibility of the high-performance membrane - from engineering points of view. Contrib Nephrol 173:11–22CrossRefPubMed
15.
go back to reference Naka T, Haase M, Bellomo R (2010) ‘Super high-flux’ or ‘high cut-off’ hemofiltration and hemodialysis. Contrib Nephrol 166:181–189CrossRefPubMed Naka T, Haase M, Bellomo R (2010) ‘Super high-flux’ or ‘high cut-off’ hemofiltration and hemodialysis. Contrib Nephrol 166:181–189CrossRefPubMed
16.
go back to reference Buus NH, Rantanen JM, Krag SP, Andersen NF, Jensen JD (2015) Hemodialysis using high cut off filters in light chain cast nephropathy. Blood Purif 40:223–231CrossRefPubMed Buus NH, Rantanen JM, Krag SP, Andersen NF, Jensen JD (2015) Hemodialysis using high cut off filters in light chain cast nephropathy. Blood Purif 40:223–231CrossRefPubMed
17.
go back to reference Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D (2012) Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant 27:3823–3828CrossRefPubMed Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D (2012) Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant 27:3823–3828CrossRefPubMed
18.
go back to reference Premru V, Kovac J, Buturovic-Ponikvar J, Ponikvar R (2013) Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure. Ther Apher Dial 17:396–401CrossRefPubMed Premru V, Kovac J, Buturovic-Ponikvar J, Ponikvar R (2013) Some kinetic considerations in high cut-off hemodiafiltration for acute myoglobinuric renal failure. Ther Apher Dial 17:396–401CrossRefPubMed
19.
go back to reference Kneis C, Beck W, Boenisch O, Klefisch F, Deppisch R, Zickler D, Schindler R (2013) Elimination of middle-sized uremic solutes with high-flux and high-cut-off membranes: a randomized in vivo study. Blood Purif 36:287–294CrossRefPubMed Kneis C, Beck W, Boenisch O, Klefisch F, Deppisch R, Zickler D, Schindler R (2013) Elimination of middle-sized uremic solutes with high-flux and high-cut-off membranes: a randomized in vivo study. Blood Purif 36:287–294CrossRefPubMed
20.
go back to reference Girndt M, Fiedler R, Martus P, Pawlak M, Storr M, Bohler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Zickler D, Schindler R (2015) High cut-off dialysis in chronic haemodialysis patients. Eur J Clin Invest 45:1333–1340CrossRefPubMed Girndt M, Fiedler R, Martus P, Pawlak M, Storr M, Bohler T, Glomb MA, Liehr K, Henning C, Templin M, Trojanowicz B, Ulrich C, Werner K, Zickler D, Schindler R (2015) High cut-off dialysis in chronic haemodialysis patients. Eur J Clin Invest 45:1333–1340CrossRefPubMed
21.
go back to reference Krieter DH, Canaud B (2003) High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant 18:651–654CrossRefPubMed Krieter DH, Canaud B (2003) High permeability of dialysis membranes: what is the limit of albumin loss? Nephrol Dial Transplant 18:651–654CrossRefPubMed
22.
go back to reference Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G (1998) Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int 54:979–985CrossRefPubMed Ronco C, Orlandini G, Brendolan A, Lupi A, La Greca G (1998) Enhancement of convective transport by internal filtration in a modified experimental hemodialyzer: technical note. Kidney Int 54:979–985CrossRefPubMed
23.
go back to reference Hasegawa T, Nakai S, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y, Akizawa T (2015) Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Am J Kidney Dis 65:899–904CrossRefPubMed Hasegawa T, Nakai S, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y, Akizawa T (2015) Dialysis fluid endotoxin level and mortality in maintenance hemodialysis: a nationwide cohort study. Am J Kidney Dis 65:899–904CrossRefPubMed
24.
go back to reference Ledebo I (2004) Ultrapure dialysis fluid: improving conventional and daily dialysis. Hemodial Int Int Symp Home Hemodial 8:159–166CrossRef Ledebo I (2004) Ultrapure dialysis fluid: improving conventional and daily dialysis. Hemodial Int Int Symp Home Hemodial 8:159–166CrossRef
25.
go back to reference Ronco C, Brendolan A, Lupi A, Metry G, Levin NW (2000) Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 58:809–817CrossRefPubMed Ronco C, Brendolan A, Lupi A, Metry G, Levin NW (2000) Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int 58:809–817CrossRefPubMed
26.
go back to reference Davenport A, Peters SA, Bots ML, Canaud B, Grooteman MP, Asci G, Locatelli F, Maduell F, Morena M, Nube MJ, Ok E, Torres F, Woodward M, Blankestijn PJ, Investigators HDFPP (2016) Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size. Kidney Int 89:193–199CrossRefPubMed Davenport A, Peters SA, Bots ML, Canaud B, Grooteman MP, Asci G, Locatelli F, Maduell F, Morena M, Nube MJ, Ok E, Torres F, Woodward M, Blankestijn PJ, Investigators HDFPP (2016) Higher convection volume exchange with online hemodiafiltration is associated with survival advantage for dialysis patients: the effect of adjustment for body size. Kidney Int 89:193–199CrossRefPubMed
27.
go back to reference Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A, Group ES (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24:487–497CrossRefPubMedPubMedCentral Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, Soler J, Torres F, Campistol JM, Martinez-Castelao A, Group ES (2013) High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. J Am Soc Nephrol 24:487–497CrossRefPubMedPubMedCentral
28.
go back to reference Maduell F, Arias-Guillen M, Fontsere N, Ojeda R, Rico N, Vera M, Elena M, Bedini JL, Wieneke P, Campistol JM (2014) Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies. Blood Purif 37:125–130CrossRefPubMed Maduell F, Arias-Guillen M, Fontsere N, Ojeda R, Rico N, Vera M, Elena M, Bedini JL, Wieneke P, Campistol JM (2014) Elimination of large uremic toxins by a dialyzer specifically designed for high-volume convective therapies. Blood Purif 37:125–130CrossRefPubMed
29.
go back to reference Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R (2009) Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 24:562–570CrossRefPubMed Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, Ledebo I, Vanholder R (2009) Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrol Dial Transplant 24:562–570CrossRefPubMed
30.
go back to reference Davenport A (2008) Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure. Int J Artif Organs 31:3–5PubMed Davenport A (2008) Potential adverse effects of replacing high volume hemofiltration exchanges on electrolyte balance and acid-base status using the current commercially available replacement solutions in patients with acute renal failure. Int J Artif Organs 31:3–5PubMed
31.
go back to reference Kumar S, Khosravi M, Massart A, Potluri M, Davenport A (2013) Haemodiafiltration results in similar changes in intracellular water and extracellular water compared to cooled haemodialysis. Am J Nephrol 37:320–324CrossRefPubMed Kumar S, Khosravi M, Massart A, Potluri M, Davenport A (2013) Haemodiafiltration results in similar changes in intracellular water and extracellular water compared to cooled haemodialysis. Am J Nephrol 37:320–324CrossRefPubMed
32.
go back to reference Lee KH, Kim DJ, Min BG, Lee SH (2007) Polymeric nanofiber web-based artificial renal microfluidic chip. Biomed Microdevices 9:435–442CrossRefPubMed Lee KH, Kim DJ, Min BG, Lee SH (2007) Polymeric nanofiber web-based artificial renal microfluidic chip. Biomed Microdevices 9:435–442CrossRefPubMed
33.
go back to reference Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P (2008) Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73:1174–1180CrossRefPubMed Meijers BK, Bammens B, De Moor B, Verbeke K, Vanrenterghem Y, Evenepoel P (2008) Free p-cresol is associated with cardiovascular disease in hemodialysis patients. Kidney Int 73:1174–1180CrossRefPubMed
34.
go back to reference Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y (2006) Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69:1081–1087 Bammens B, Evenepoel P, Keuleers H, Verbeke K, Vanrenterghem Y (2006) Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int 69:1081–1087
35.
go back to reference Kandouz S, Mohamed AS, Zheng Y, Sandeman S, Davenport A (2016) Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration. Hemodial Int 20:610–617CrossRefPubMed Kandouz S, Mohamed AS, Zheng Y, Sandeman S, Davenport A (2016) Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration. Hemodial Int 20:610–617CrossRefPubMed
36.
go back to reference Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B (2010) Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 25:212–218CrossRefPubMed Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, Wanner C, Canaud B (2010) Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrol Dial Transplant 25:212–218CrossRefPubMed
37.
go back to reference Sirich TL, Luo FJ, Plummer NS, Hostetter TH, Meyer TW (2012) Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant 27:1574–1579CrossRefPubMedPubMedCentral Sirich TL, Luo FJ, Plummer NS, Hostetter TH, Meyer TW (2012) Selectively increasing the clearance of protein-bound uremic solutes. Nephrol Dial Transplant 27:1574–1579CrossRefPubMedPubMedCentral
38.
go back to reference Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW (2009) Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. Am J Kidney Dis 53:1042–1049CrossRefPubMed Luo FJ, Patel KP, Marquez IO, Plummer NS, Hostetter TH, Meyer TW (2009) Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial. Am J Kidney Dis 53:1042–1049CrossRefPubMed
39.
go back to reference De Smet R, Dhondt A, Eloot S, Galli F, Waterloos MA, Vanholder R (2007) Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes. Nephrol Dial Transplant 22:2006–2012CrossRefPubMed De Smet R, Dhondt A, Eloot S, Galli F, Waterloos MA, Vanholder R (2007) Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes. Nephrol Dial Transplant 22:2006–2012CrossRefPubMed
40.
go back to reference Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS, Group FHNT (2013) Effect of frequent hemodialysis on residual kidney function. Kidney Int 83:949–958CrossRefPubMedPubMedCentral Daugirdas JT, Greene T, Rocco MV, Kaysen GA, Depner TA, Levin NW, Chertow GM, Ornt DB, Raimann JG, Larive B, Kliger AS, Group FHNT (2013) Effect of frequent hemodialysis on residual kidney function. Kidney Int 83:949–958CrossRefPubMedPubMedCentral
41.
go back to reference Krieter DH, Devine E, Korner T, Ruth M, Wanner C, Raine M, Jankowski J, Lemke HD (2017) Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal. Acta Physiol 219:510–520CrossRef Krieter DH, Devine E, Korner T, Ruth M, Wanner C, Raine M, Jankowski J, Lemke HD (2017) Haemodiafiltration at increased plasma ionic strength for improved protein-bound toxin removal. Acta Physiol 219:510–520CrossRef
42.
go back to reference Tao X, Thijssen S, Kotanko P, Ho CH, Henrie M, Stroup E, Handelman G (2016) Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Sci Rep 6:23389CrossRefPubMedPubMedCentral Tao X, Thijssen S, Kotanko P, Ho CH, Henrie M, Stroup E, Handelman G (2016) Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study. Sci Rep 6:23389CrossRefPubMedPubMedCentral
43.
go back to reference Hirsh SL, McKenzie DR, Nosworthy NJ, Denman JA, Sezerman OU, Bilek MM (2013) The Vroman effect: competitive protein exchange with dynamic multilayer protein aggregates. Colloids Surf B Biointerfaces 103:395–404CrossRefPubMed Hirsh SL, McKenzie DR, Nosworthy NJ, Denman JA, Sezerman OU, Bilek MM (2013) The Vroman effect: competitive protein exchange with dynamic multilayer protein aggregates. Colloids Surf B Biointerfaces 103:395–404CrossRefPubMed
44.
go back to reference Clark WR, Macias WL, Molitoris BA, Wang NH (1995) Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 48:481–488CrossRefPubMed Clark WR, Macias WL, Molitoris BA, Wang NH (1995) Plasma protein adsorption to highly permeable hemodialysis membranes. Kidney Int 48:481–488CrossRefPubMed
45.
go back to reference Tessitore N, Lapolla A, Arico NC, Poli A, Gammaro L, Bassi A, Bedogna V, Corgnati A, Reitano R, Fedele D, Lupo A (2004) Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. J Nephrol 17:707–714PubMed Tessitore N, Lapolla A, Arico NC, Poli A, Gammaro L, Bassi A, Bedogna V, Corgnati A, Reitano R, Fedele D, Lupo A (2004) Effect of protein leaking BK-F PMMA-based hemodialysis on plasma pentosidine levels. J Nephrol 17:707–714PubMed
46.
go back to reference Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, Buoncristiani E, Floridi A (2003) The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 64:748–755CrossRefPubMed Galli F, Benedetti S, Buoncristiani U, Piroddi M, Conte C, Canestrari F, Buoncristiani E, Floridi A (2003) The effect of PMMA-based protein-leaking dialyzers on plasma homocysteine levels. Kidney Int 64:748–755CrossRefPubMed
47.
go back to reference Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, La Greca G, Levin NW (2001) First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis. Blood Purif 19:260–263CrossRefPubMed Ronco C, Brendolan A, Winchester JF, Golds E, Clemmer J, Polaschegg HD, Muller TE, La Greca G, Levin NW (2001) First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta(2)-microglobulin in hemodialysis. Blood Purif 19:260–263CrossRefPubMed
48.
go back to reference Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH (2007) Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18:868–874CrossRefPubMed Meyer TW, Peattie JW, Miller JD, Dinh DC, Recht NS, Walther JL, Hostetter TH (2007) Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate. J Am Soc Nephrol 18:868–874CrossRefPubMed
49.
go back to reference Sandeman SR, Howell CA, Phillips GJ, Zheng Y, Standen G, Pletzenauer R, Davenport A, Basnayake K, Boyd O, Holt S, Mikhalovsky SV (2014) An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med 25:1589–1597CrossRefPubMedPubMedCentral Sandeman SR, Howell CA, Phillips GJ, Zheng Y, Standen G, Pletzenauer R, Davenport A, Basnayake K, Boyd O, Holt S, Mikhalovsky SV (2014) An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis. J Mater Sci Mater Med 25:1589–1597CrossRefPubMedPubMedCentral
50.
go back to reference Tijink MS, Wester M, Glorieux G, Gerritsen KG, Sun J, Swart PC, Borneman Z, Wessling M, Vanholder R, Joles JA, Stamatialis D (2013) Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma) Biomaterials 34:7819–7828CrossRefPubMed Tijink MS, Wester M, Glorieux G, Gerritsen KG, Sun J, Swart PC, Borneman Z, Wessling M, Vanholder R, Joles JA, Stamatialis D (2013) Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma) Biomaterials 34:7819–7828CrossRefPubMed
51.
go back to reference Betjes MG, Hoekstra FM, Klepper M, Postma SM, Vaessen LM (2004) Vitamin E-coated dialyzer membranes downregulate expression of monocyte adhesion and co-stimulatory molecules. Blood Purif 22:510–517CrossRefPubMed Betjes MG, Hoekstra FM, Klepper M, Postma SM, Vaessen LM (2004) Vitamin E-coated dialyzer membranes downregulate expression of monocyte adhesion and co-stimulatory molecules. Blood Purif 22:510–517CrossRefPubMed
52.
go back to reference Yang SK, Xiao L, Xu B, Xu XX, Liu FY, Sun L (2014) Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Renal Fail 36:722–731CrossRef Yang SK, Xiao L, Xu B, Xu XX, Liu FY, Sun L (2014) Effects of vitamin E-coated dialyzer on oxidative stress and inflammation status in hemodialysis patients: a systematic review and meta-analysis. Renal Fail 36:722–731CrossRef
53.
go back to reference Islam MS, Hassan ZA, Chalmin F, Vido S, Berrada M, Verhelst D, Donnadieu P, Moranne O, Esnault VL (2016) Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: a multicenter, randomized, crossover trial. Am J Kidney Dis 68:752–762CrossRefPubMed Islam MS, Hassan ZA, Chalmin F, Vido S, Berrada M, Verhelst D, Donnadieu P, Moranne O, Esnault VL (2016) Vitamin E-coated and heparin-coated dialyzer membranes for heparin-free hemodialysis: a multicenter, randomized, crossover trial. Am J Kidney Dis 68:752–762CrossRefPubMed
Metadata
Title
Enhancing dialyser clearance—from target to development
Authors
Kamonwan Tangvoraphonkchai
Andrew Davenport
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 12/2017
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-017-3647-y

Other articles of this Issue 12/2017

Pediatric Nephrology 12/2017 Go to the issue